For more information: www.worldcongress.com/claimsanalysis
Phone: 800-767-9499
Read More
In politics and professional life, achieving success requires the ability to resolve conflicts. I’ve noticed that conflicts often become entrenched because the opposing parties both simplify the conflict in black and white terms. They conceptualize their own interest as moving in one direction. And, they conceptualize their opponent as wanting to move in the opposite, wrong direction. As a result, the argument between the parties generates no light, only heat. Each side only acknowledges the advantages of their direction and the disadvantages of the opposing direction. Neither side seeks to really understand and learn from the arguments offered by the other side.
When I’ve had the opportunity to mediate such conflicts, I almost always used the same strategies.

Of course, in the routine work of mediating conflicts, I don’t really explicitly go through these six steps. This conflict resolution approach is in the back of my mind. They are really more like habits than steps.
Sometimes this approach works. Sometimes, it does not. It can break at any step.
Notice that break downs in most of the steps are basically people issues. People won’t change their conceptualization. They are unwilling to make their assumptions explicit. They are unwilling to acknowledge differences in values. They are unwilling to compromise.
But, sometimes, the process breaks because of the nature of the issue being debated. Sometimes, conceptualizing the debate as an optimization problem between two undesirable extremes fails because there are really not good choices along the spectrum.
For example, when debating the design of a program or policy, I have often encountered a no-win trade-off between keeping it simple vs. addressing each party’s unique circumstances. If I keep it too simple, people complain that it as a “hammer,” failing to deal with their circumstances. If I add complexity to deal with all the circumstances, people complain that it is a maze or a contraption. If I select some middle level of complexity, the complaints are even worse because the pain of complexity kicks in before the value of complexity is achieved.
I’ve seen this no-way-to-win scenario in my own work, in the design of information systems, wellness and care management protocols, practice guidelines and protocols, analytic models, organizational structures, governance processes, contractual terms, and provider incentive programs. And, I’ve seen this scenario in many public policy debates, such as debates about tax policy, tariffs, banking regulations, immigration, education, and health care reform. In cases when the extremes are more desirable than the middle ground, the only approach I can think of is to bundle multiple issues together so that one party wins some and the other party wins others, to facilitate compromise.
Read MoreLyle Nelson from the Congressional Budget Office (CBO) has been busy.
Two weeks ago, I commented on the results of Nelson’s review of 6 Medicare Care Management demonstration projects over the last decade. At the same time that report was released, Nelson also released a companion report on the 4 “Value-based Payment” CMS demonstrations over the same period. The following is my adaptation of the main results table in this new CBO report.
The most influential of these demonstrations was the Physician Group Practice Demonstration (PGP). The ten PGP participants included 2 faculty group practices within academic medical centers, 5 non-academic integrated delivery systems, one freestanding group practice, and one network consisting of 60 small practices. All had experience with care management programs before the demonstration, and all implemented care management programs in the Medicare population for the demonstration. These care management programs mostly consisted of nurses serving as care managers, focusing primarily on patient education and monitoring for patients with CHF or diabetes or meeting other “high risk” criteria. Most implemented chronic disease registries for use by the care managers, in addition to using electronic medical records systems that were already in place or in the process of being implemented before the start of the demonstration.
Two of the ten PGP participants received bonuses in the first year, since the Medicare expenditures were more than 2% below the expected expense. Four participants received bonuses in the second year, five in the third and fourth years, and four in the fifth year. A formal evaluation of the program conducted after the first two years concluded that the overall effectiveness of the PGP across the ten participants was about 1% gross savings in year two, and even lower in year one. Net savings, after counting the cost of the bonuses paid to some of the participants, was only 0.1% in year two.
The CBO report points out that even this meager 0.1% net savings might be an over-estimate, because PGP participants changed their diagnostic coding practices, making their populations appear to be sicker, and therefore making the risk-adjusted cost targets artificially high. Such revenue maximization efforts have been job one in Medicare Advantage plans for years. The PGP participants succeeded in lifting their risk scores by 8%, which was 3 percentage points higher than the increase in the comparison population. And, the savings might have been further overestimated because all four of the PGP participants that achieved reward payments in year two already had slower than normal growth in Medicare expenditures before the PGP demonstration began. All the other PGP participants that did not earn year 2 bonuses had pre-demonstration Medicare growth that was no different than the comparison population.
Despite these discouraging results, the PGP demonstration was nevertheless used as the main evidence base supporting the design of the Medicare Shared Savings Program, calling for the establishment of Accountable Care Organizations (ACOs). It is also the main evidence base for the associated Pioneer ACO program, for which 32 participating provider organizations have recently been selected.
The Premier Hospital Quality Demonstration focused on 5 disease states and made bonus payments that amounted to only 0.25% of the total Medicare payments for those disease states. That’s two orders of magnitude less than the size of incentive payments thought to substantially influence performance. With such a tiny prize, it is not surprising that the quality improvements were assessed to have only a 1-5% incremental impact of process of care quality metrics during a period of time when such process of care metrics were improving nationally. And, the CBO report concluded that the demonstration had no effect on Medicare expenditures for inpatient hospital care. In fact, taking into consideration the reward payments, the demonstration led to an increase of costs by 0.3%.
The most successful of the demonstration projects was the Medicare Participating Heart Bypass Center Demonstration, which was used as a model for similar provisions in the health care reform law (PPACA). In this program, the hospitals negotiated their bundled payments up front, ensuring that Medicare received savings compared to typical fee-for-service cases. Overall, the program saved Medicare 10%.
So, where did the savings come from?
It’s possible that they just came from good negotiating by CMS with hospitals that wanted to get out in front of what they saw was an inevitable trend toward bundled payment. But, let’s assume that the hospitals really had a plan to reduce their costs in proportion to the negotiated decline in their revenue.
In interviews with leaders of the participating hospitals, the important changes in their approaches to patient management that were intended to reduce their costs included:
The participating hospitals substantially decreased their length of stay during the demonstration period, although length of stay for bypass surgery was dramatically decreasing nationally during that same time period.
However, probably more important than these process changes was the fact that all the participating hospitals created a physician reimbursement approach that established a fixed per case payment expected to cover all physician payments. This amount was split in defined percentages among the four types of specialists involved in every bypass case — the thoracic surgeon, cardiologist, anesthesiologist, and radiologist. Any payments to other specialists was essentially payed from this pool, reducing the payments to the four core specialties. Therefore, the hospitals created a strong incentive for the core specialties to limit referrals to other specialists. This undoubtedly led to a reduction in utilization of those other specialists and the tests and procedures they generate. Therefore, some of the savings probably came from reducing revenue to non-core specialists.
My conclusions
My father recently forwarded an e-mail he received from a friend with a link to a TV news story about a physician who treated her own husband’s worsening Alzheimer’s disease with coconut oil. My father is interested in the topic, particularly since he knows someone who suffered and died from the disease. He forwarded the e-mail to me, asking my opinion.
The physician, Mary Newport, MD, is a neonatologist. She explains that Alzheimer’s is thought to be similar to diabetes in that it involves an impairment in the ability of brain cells to respond to insulin and take in the glucose needed to provide energy. As a result, brain cells die and eventually brain function is reduced. She reasoned that the brain cells may avoid death by relying on an alternative fuel, ketones. She identified coconut oil as a good dietary source of ketones. So, she introduced coconut oil into her husband’s diet and noted improvement in his brain function. She documented this improvement with a “clock test,” showing how a hand drawing of the face of a clock done after initiation of coconut oil treatment was more coherent and detailed that a drawing done before the treatment. Excited by the promising results, she wrote a book, started a web-site, and started doing radio and TV interviews to disseminate information about her new treatment.
From the simple explanation, it seems biologically plausible. And, I’m sure that Dr. Newport had nothing but the best intentions, motivated by love for her husband and a desire to help millions of people suffering from Alzheimer’s. And, it is possible that she is absolutely right. Coconut oil may be a simple, inexpensive, non-invasive, effective treatment for the disease.
But, obviously, we would not want to make decisions about treatments from a single data point, where the main outcomes measurement was a subjective assessment about how coherent a hand drawing of a clock was.
It would have been more appropriate for this physician to actually do the work of scientific research before disseminating results. That would start with writing a study proposal, convincing peers in a study committee for a research granting agency that it was a plausible and promising idea. Then, she would conduct a randomized study, making objective measurements or collecting careful observations by impartial observers. Then, she would analyze the results to see if there is a statistically significant difference in the outcomes between the treatment group and the control group. The purpose of the statistical significance test is to assure that there is a low probability that any observed differences are just due to chance. Finally, she would do the work of writing up a paper and submitting it to a peer reviewed journal to convince expert reviewers that there were no obvious flaws in the methodology. Only then should she consider further dissemination of the information, such as by writing a book, starting her own web site, and doing TV and radio interviews.
The scientific approach to medical innovation has served us well as a society. When this physician went straight from one observation to TV interviews, she short-cut the scientific approach. She may be helping people with Alzheimer’s. But, she may potentially be distracting Alzheimer’s patients from seeking proven treatments or diverting funding away from competing innovative treatment ideas that have gone through the scientific “front door.” More generally, she may be harming our society’s commitment to a scientific approach.
The fact that the treatment is a type of food, rather than a patentable drug, admittedly changes the situation. No drug company wants to fund research on coconut oil. And, the coconut oil industry is not familiar with clinical research, even if they could benefit from increased demand for treatment of Alzheimer’s. This is a good argument for why the National Institutes of Health and private research foundations should fund more research related to diet and natural remedies. It should not be an argument for short-circuiting the scientific approach to health care innovation.
Fortunately, a research team from Oxford is pursuing a randomized clinical trial to test the use of dietary ketones as a treatment for Alzheimer’s. The Oxford team is testing a specialized ketone ester that is thought to be ten times better than coconut oil in terms of delivering ketones to the interior of brain cells. Results should be available later this year. Hopefully, they will show meaningful improvement.
Read MoreThis month, Lyle Nelson of the Congressional Budget Office (CBO) released a “working paper” summarizing the results of a decade of experience with 6 care management demonstration projects in the Medicare population. These demonstrations included a total of 34 disease management or care coordination programs. Nelson briefly summarized the working paper in a recent blog post.
All of the 34 care management programs were designed to reduce Medicare costs primarily by maintaining or improving the health of the Medicare beneficiaries, and thereby reducing the need for expensive inpatient hospital stays. As shown the graph below, different programs showed different effects on the rate of hospital admissions. On average, the programs showed no effect.

Effects of 34 Disease Management and Care Coordination Programs on Hospital Admissions (Percentage Change in Hospital Admissions)
The CBO analyzed whether specific characteristics of programs led to better or worse results. They found that programs where the care management provider’s fees were at risk did not perform better or worse than those with fees not at risk. However, they did find two things that worked. They found that programs in which care managers had substantial direct interaction with physicians and those with significant in-person interaction with patients reduced hospital admissions by an average of 7%, while programs that did not have these features had no impact on hospital admissions.
But, after subtracting the cost of the programs themselves, almost none of the programs achieved net savings.
The programs with the most compelling performance included:
The methods used for these evaluations were far stronger than those used by the self-evaluations typically advertised by vendors of care management services. In the CBO reports, 30 of the 34 programs were evaluated based on a comparison to a randomly selected comparison group. The remaining 4 programs were evaluated using a concurrent comparison group selected using the same selection criteria. In all cases, the programs were evaluated on an “intent to treat” basis, where study subjects were included in the evaluation regardless of whether they participated in the voluntary programs, thereby removing a source of bias that causes mischief in less rigorous evaluations.
To me, the take-away message is that provider-based care management is promising, but health-plan-style telephonic care management has not been successful, even in a senior population, where finding high risk targets is far easier and even when the care management services provider is highly motivated to succeed.
Read MoreToday, a number of web sites, including the amazingly useful Wikipedia.org site, have gone black to protest proposed anti-piracy legislation making its way through the U.S. Congress.
On the one hand, the entertainment industry does face a real problem as people are so easily able to steal their product and widely distribute it to people in the US using social network and other tools based outside of the US. So, I can see why they are trying to get as much power as they can to shut that down through any of the U.S-based parties that are involved, such as search engines, web site hosts, and credit card clearinghouses.
From their perspective, all that talk about the importance of the internet as a vehicle for freedom and political change is a bit insincere coming from parties that are just trying to make a buck knowingly casting a blind eye to the fact that their customers are deriving a big part of the value of using their services by accessing stolen content. The entertainment industry is basically just saying that if such parties are not putting in a reasonable amount of effort to block that, they should be considered accomplices to the theft.
But, on balance, I do side with the protesters. The definition of reasonable amount of effort can very easily become a slippery slope to requiring tiny start-ups to buy unaffordable technology and putting in an unaffordable amount of manual labor into avoiding being accused of being an accomplish to someone else’s crime. I agree with the protesters that this could easily stifle such start-ups, which would not displease the established big entertainment players. The entire US-based entertainment industry is just not a very big part of the overall economy, and the internet has become an indispensable part of the entrepreneurship, innovation, political discourse, and social interaction that moves society forward. The unintended consequences of the proposed SOPA/PIPA legislation, both directly in the US and on the precedent-setting impact on laws in other countries, could be huge and are not worth squeezing a few more dollars out of one small sector of our economy.
Therefore, we should reject the SOPA and PIPA legislation, and continue to pursue more incremental efforts to thwart internet piracy.
More information at http://en.wikipedia.org/wiki/Wikipedia:SOPA_initiative/Learn_more
Read MoreThe Centers for Medicare and Medicaid Services (CMS) announced the final list of 32 health care provider organizations that are to participate in the “Pioneer ACO” program during 2012.
The Pioneer ACO program was intended to allow provider organizations that had experience and sophisticated population management and care coordination capabilities to get started under a gain-sharing arrangement for Medicare more quickly than the Medicare Shared Savings Program (MSSP). Compared to the MSSP participants, these Pioneer ACOs will take on greater risk and will be eligible to receive higher gain-sharing payments. They will then have an opportunity to move more rapidly from a gain-sharing to a population-based full-risk capitation payment model in year three, as long as they successfully earned shared savings awards during the first two years. They will then be allowed to continue through an optional fourth and fifth year. The Pioneer ACOs all commit to negotiating “outcomes-based” reimbursement arrangements with other payers by the end of the second year.
Of the 32 Pioneer ACOs, more than one third are physician organizations, with the remainder being integrated delivery systems or other structures that include both hospital facilities and physicians.
The majority of the Pioneer ACOs are concentrated in 5 states, with California predictably leading the pack with 6 Pioneers, followed by Maine, Michigan, Minnesota and Texas.

The three Michigan-based ACOs include:
The full list of Pioneer ACOs follows:
CMS released a fact sheet with more details about the Pioneer ACO program.
Read MoreDuring the last 20 years, we have experienced wave after wave of new frameworks for improving health care. Each had its own terminology, ardently promoted and enforced by its zealous advocates. Each had a lifecycle that began with a long incubation period, followed by a period of explosive growth in popularity and influence, rapidly leading to unrealistic expectations, followed by a period of decline during which the framework was declared to have been ineffective. We’ve been through health maintenance, outcomes management, clinical effectiveness, managed care, disease management, chronic care, care management, practice guidelines, care maps, evidence-based medicine, quality functional deployment, continuous quality improvement, re-engineering, total quality management, and six sigma. We’re still in the thick of lean, patient-centered care, value-based benefits, pay-for-performance and accountable care.
Four things I’ve noticed about this lifecycle of health care improvement frameworks:
This last point reminds me of the “humunculus,” also called the “little man.” When I was in medical school in the late 1980s, we used heavy text books that generally did a bad job of teaching the information. One notable exception was clinical neuroanatomy. We used a small, paperback text book playfully entitled “Clinical Neuroanatomy Made Ridiculously Simple” by Stephen Goldberg, MD. It contained a collection of clever drawings designed to explain the structures and functions of the brain and spinal cord. Perhaps the most famous of the drawings was the humunculus.
This drawing was adapted from earlier work by an innovative neurosurgeon named Wilder Penfield, who invented new surgical procedures for patients with epilepsy during the late 1930s. During those procedures, he used electrodes to stimulate different points on the surface of the brain. He drew diagrams similar to the drawing above showing that the surface of the brain contained a little man hanging upside down. The diagram shows that a disproportionate portion of the brain surface is dedicated to the sense of touch and muscle movements in certain parts of the body. Lots of brain surface is dedicated to highly sensitive and nimble areas like the lips, tongue, hands and feet. Very little brain surface is dedicated to the arms, legs and back. Many anatomic illustrators have drawn the humunculus as a cartoon character showing how this disproportional emphasis on different parts of the body looks on the little man.
The humunculus is a great teaching tool, making it easy to remember these aspects of clinical neuroanatomy. But, I think the humunculus is also a useful metaphor for the distorted emphasis that various health care improvement frameworks have placed on various parts of the underlying anatomy of health care improvement.
Framework |
Emphasis |
| Health maintenance | Preventive services |
| Outcomes Management | Measurement of function, patient experience and health status |
| Clinical Effectiveness | Measurement of outcomes in real world settings, rather than laboratory controlled conditions |
| Managed Care | Prospective review of appropriateness of referrals, procedures and expensive drugs, and retrospective review of cost of care |
| Disease Management | Role of nurses in training patients to be more effective in self-management |
| Chronic Care | Teamwork in primary care clinic and importance of organizational and community environment |
| Care Management | Role of nurses in coordinating services delivered by different providers and in different settings |
| Practice Guidelines | Consensus about which ambulatory services are appropriate in which situations |
| Care Maps | Consensus about the sequence of inpatient services for different diagnoses |
| Evidence-based Medicine | Weight of scientific evidence about efficacy of a service (without regard to cost) |
| Quality Functional Deployment | Focus on the demands made by patients |
| Continuous quality improvement | Small experiments to determine if incremental process changes are improvements |
| Re-engineering | Designing new processes from scratch, rather than making incremental changes |
| Total Quality Management | Importance of organizational culture and management processes |
| Six Sigma | Focus on reducing frequency of defects |
| Lean | Focus on eliminating non-value-adding process steps and reducing cycle time |
| Patient-centered care | Focus on the needs of patients and the involvement of patients in their own care |
| Value-based Benefits | Financial incentives to motivate patients to comply with recommended treatments that reduce overall cost |
| Pay-for-performance | Financial incentives to motivate individual physicians to improve quality and reduce cost |
| Accountable care | Financial incentives to motivate health care organizations to improve quality and reduce cost |
Over the years, I have assimilated the concepts, terminology and tools from these various improvement frameworks into an approach that attempts to achieve balance, with each aspect of the framework shown without over-emphasis.
This framework puts the patient in the center, surrounded by the health care processes, which are surrounded by improvement processes. It attempts to balance between focusing on care planning (the clinical decision-making regarding what services are needed) vs. focusing on care-delivery (the teamwork to execute the care plan and provide health care services to the patient). It balances between measuring outcomes and measuring quality and cost performance. It balances between implementing best practices through guidelines and protocols vs. improving practices through performance feedback and incentives. By avoiding a distorted over-emphasis on any one part of the anatomy, hopefully it can have greater lasting power than some of the more humunculus-like frameworks that have come and gone. This framework is described more fully here.
Read MoreLast week, Don Berwick, MD, announced his resignation as Administrator of the Centers for Medicare and Medicaid Services (CMS). Now is a good time to explain why Dr. Berwick is one of my all time health care heroes.
Apparently, I talk about Dr. Berwick a lot. A few years ago, I received one of my most treasured gifts from colleagues at Blue Cross Blue Shield of Michigan (BCBSM). It was a coffee mug featuring the famous photograph of the Four Horsemen of Notre Dame, a reference to my undergraduate alma mater. My colleagues replaced the faces of three of the horsemen with the faces of three of my health care heroes, Drs. Paul Ellwood (the person who coined the terms “health management organization” and “outcomes management”), David Eddy (the clearest thinker on the topics of clinical practice policies and the rational allocation of health care resources), and Don Berwick. The face of the forth horseman they replaced with my own face. I considered it a great honor to be associated with my heroes, at least on a coffee mug.
My team at BCBSM had heard me repeatedly explain Dr. Berwick’s important contribution to adapting the quality improvement principles that had been successfully used in manufacturing to the health care field. Others had been involved in promoting “continuous quality improvement,” “statistical process control,” and “total quality management” in health care. Paul Batalden, Brent James, Eugene Nelson, and Jack Billi come to mind, to name but a few. But, in my opinion, it has always been Berwick that has been the most eloquent and persuasive. He connected the statistical tools emphasized by James with the front line worker involvement emphasized by Batalden. And, he was able to describe how these approaches applied to clinical decision-making as well as care delivery.
At the heart of Dr. Berwick’s contribution was teaching us all to distinguish between the “Theory of Bad Apples” and the “Theory of Continuous Improvement.”
According to the Theory of Bad Apples, errors come from “shoddy work” by people with deficient work performance. Leaders who uphold this theory focus on inspection to identify such deficient performance, indicated by the undesirable tail in the distribution of provider performance as shown on the left side of the diagram above. Then, such leaders focus on holding the bad performers “accountable” by applying disciplinary measures intended to motivate improvement in performance and by pursuing other interventions intended to re-mediate the bad performance. In the health care context, the workers are physicians and the shoddy work is poor quality health care. According to Berwick, the predictable defensive response by the physicians who are targeted for such remedial attention includes three elements: (1) kill the messenger, (2) distort the data and (3) blame somebody else.
Berwick advocates instead for the Theory of Continuous Improvement. The basic principles of this theory are
Berwick argued the point made by Dr. Deming: if we can reduce fear, people will not try to distort the data. When learning is guided by accurate information and sound rules of inference, when suppliers of service remain in dialog with those that depend upon them, and “when the hearts and talents of workers are enlisted in the pursuit of better ways, the potential for improvement in quality in nearly boundless.”
I first was influenced by Dr. Berwick back in the 1980′s when he championed these ideas during his tenure at the Harvard Community Health Plan, and subsequently during the 1990′s when he led the National Demonstration Project on Quality Improvement in Health Care and the Institute for Healthcare Improvement. His face was already on my coffee mug at the time he was nominated to lead CMS. I was thrilled that someone from our community of people dedicated to clinical process improvement had been recognized and would be serving in a position of such influence.
The Irony of the Political Opposition to Berwick’s Role as CMS Administrator
Dr. Berwick’s candidacy as CMS Administrator faced stiff opposition from Republican leaders who were angry about anything connected to the health care reform law or, for that matter, the Obama administration itself. The President made the decision to evade this opposition by making a recess appointment of Dr. Berwick. But, such recess appointments have a limited lifespan. As the deadline for making a formal, congressionally sanctioned appointment approached at the end of the 2011 legislative session, 42 Republican senators signed a letter reiterating their disapproval of Dr. Berwick as CMS Administrator. The arguments against Dr. Berwick’s candidacy, both at the time of his original nomination and again over the last few months, centered around comments that Dr. Berwick has made praising the British health care system. They concluded from his comments that he was in favor of redistributing wealth to the poor and of rationing, the dreaded “R” word, the thing done by “death panels!” He was, therefore both a bleeding heart and heartless at the same time. Dr. Berwick denied these charges, but the opposition was unconvinced and unwilling to back down from a position of persistent opposition to anything connected to “Obamacare.”
The irony is that, of the heroes on my coffee mug, Dr. Berwick is not the one deserving of praise for having insight and bravery concerning the basic tenets of health economics. Instead, it was Dr. David Eddy’s mug that was on my coffee mug because he was brave enough to publish numerous papers in the Journal of the American Medical Association explaining why rationing was the right thing to do (e.g. this one and another one). Eddy argued that creating evidence-based “practice policies” that rationally allocated health care resources using “explicit methods” was favorable to using implicit methods supported only by “global subjective judgement.” What a radical thought!
Despite my great admiration for Dr. Berwick, he was the hero that disappointed me as a rationing denier. In fact, in a 2009 paper published in Health Affairs entitled “What ‘Patient-Centered’ Should Mean: Confessions of an Extremist,” he eloquently argued that we should give any patient whatever they wanted, regardless of the cost and regardless of the evidence of effectiveness. He discounted the role of the physician as a steward of resources. I felt the argument was heartfelt and humanistic. But, I felt it was a cop out. How strange, then, that the Republican opposition hoisted him on the rationing petard.
Looking Forward to Berwick’s Next Journey
Although it is disappointing to me that Dr. Berwick will no longer be leading CMS, I am eager to see what he chooses to do next. I’m sure he will continue to make a great contribution to our field. Without all the administrative and political duties to clog up his day, perhaps we are about to witness a surge in his ongoing contributions to improving health care.
More information: See Health Affairs article and associated Health Affairs Blog Post praising Dr. Berwick.
Read More